NCT/Study#

NCT02500407 /

GO29781

An Open-Label, Multicenter, Phase I Trial Evaluating the Safety and Pharmacokinetics of Escalating Doses of BTCT4465A In Patients with Relapsed or Refractory B-Cell Non-Hodgkin?s Lymphoma and Chronic Lymphocytic Leukemia

An Open-Label, Multicenter, Phase I Trial Evaluating the Safety and Pharmacokinetics of Escalating Doses of BTCT4465A In Patients with Relapsed or Refractory B-Cell Non-Hodgkin?s Lymphoma and Chronic Lymphocytic Leukemia

DISEASE GROUP:
Lymphoma
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: